Hikma Pharmaceuticals Plc Director/PDMR Shareholding
June 05 2024 - 9:53AM
RNS Regulatory News
RNS Number : 2745R
Hikma Pharmaceuticals Plc
05 June 2024
Hikma Pharmaceuticals
PLC
Notification and public
disclosure of transactions by persons discharging managerial
responsibilities
|
1
|
Details of the person discharging
managerial responsibilities / person closely associated
|
|
a)
|
Name
|
Said Darwazah
|
|
2
|
Reason for the
notification
|
|
a)
|
Position/status
|
Executive Chairman
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission
allowance market participant, auction platform, auctioneer or
auction monitor
|
|
a)
|
Name
|
Hikma Pharmaceuticals PLC
|
|
b)
|
LEI
|
549300BNS685UXH4JI75
|
|
4
|
Details of the transaction(s):
section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date; and (iv) each place where
transactions have been conducted
|
|
a)
|
Description of the financial
instrument, type of instrument and identification code
|
Description: Ordinary shares of 10
pence each
ID Code: GB00B0LCW083
|
|
b)
|
Nature of the transaction
|
Grant of a pledge by the Executive
Chairman over 820,416 Ordinary Shares of 10 pence each in Hikma
Pharmaceuticals PLC in favour of EFG Private Bank UK
Limited.
|
|
c)
|
Price(s) and volume(s)
|
Price(s): £0.00p
Volume(s): 820,416
|
|
d)
|
Aggregated information
|
Aggregated volume:
820,416
Price: £0.00p
|
|
e)
|
Date of the transaction
|
31 May 2024
|
|
f)
|
Place of the transaction
|
Outside a trading venue
|
Helen
Middlemist
Group Company
Secretary
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHBXGDLDUGDGSU
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Nov 2024 to Dec 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Dec 2023 to Dec 2024
